Qi Biodesign secures $75M for genome editing technology
Qi Biodesign, a company involved in genome editing technologies, announced it has completed a $75 million funding round, which includes seed funding and Series Pre-A and Series A stages.Beijing Medical and Health Care Industry…
Continue Reading